Literature DB >> 6486908

Resection of terminal vagal branches to parietal cell mass in the treatment of duodenal ulcer.

J M Sun, P Zhang, H Shang.   

Abstract

In order to completely denervate the parietal cell mass and to prevent the undesirable side effects of highly selective vagotomy, the authors devised a new and simpler modified operative procedure. First, the anterior and posterior leaves of the lesser omentum are divided from the stomach at their attachment 6 cm proximal to the pylorus to the level 2 to 2.5 cm below the esophagogastric junction. Second, a circular seromuscular incision is made at the anterior and posterior wall of the stomach from the lesser curve 2 to 2.5 cm below the cardia to the highest short gastric artery at the greater curve. Forty cases followed for an average period of 21.8 months with satisfactory postoperative results reported.

Entities:  

Mesh:

Year:  1984        PMID: 6486908      PMCID: PMC1250540          DOI: 10.1097/00000658-198411000-00005

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  5 in total

1.  A technique for highly selective (parietal cell or proximal gastric) vagotomy for duodenal ulcer.

Authors:  J C Goligher
Journal:  Br J Surg       Date:  1974-05       Impact factor: 6.939

2.  Anterior highly selective vagotomy with posterior truncal vagotomy: a simple technique for denervating the parietal cell mass.

Authors:  G L Hill; M C Barker
Journal:  Br J Surg       Date:  1978-10       Impact factor: 6.939

3.  Highly selective vagotomy and pyloric dilatation for duodenal ulcer with stenosis.

Authors:  D C Dunn; W E Thomas; J O Hunter
Journal:  Br J Surg       Date:  1981-03       Impact factor: 6.939

4.  Early results of simplified proximal high selective transgastric vagotomy without drainage.

Authors:  P C Petropoulos
Journal:  Surg Gynecol Obstet       Date:  1980-02

5.  Lesser curve superficial seromyotomy--an operation for chronic duodenal ulcer.

Authors:  T V Taylor
Journal:  Br J Surg       Date:  1979-10       Impact factor: 6.939

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.